Theresa G. Wingrove
Net Worth

Last updated:

What is Theresa G. Wingrove net worth?

The estimated net worth of Dr. Theresa G. Wingrove is at least $29,296,265 as of 5 Feb 2024. He has earned $23,265,955 from insider trading and has received compensation worth at least $6,030,310 in ImmunoGen, Inc..

What is the salary of Theresa G. Wingrove?

Dr. Theresa G. Wingrove salary is $548,210 per year as Senior Vice President of Regulatory Affairs & Quality in ImmunoGen, Inc..

How old is Theresa G. Wingrove?

Dr. Theresa G. Wingrove is 67 years old, born in 1958.

What stocks does Theresa G. Wingrove currently own?

As insider, Dr. Theresa G. Wingrove owns shares in one company:

Company Title Shares Price per share Total value
ImmunoGen, Inc. (IMGN) Senior Vice President of Regulatory Affairs & Quality 21,039 $0 $0

What does ImmunoGen, Inc. do?

ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Its preclinical programs include IMGC936, an ADC in co-development with MacroGenics, Inc.; and IMGN151, an anti FRa product candidate. The company has collaborations with Roche; Amgen/Oxford BioTherapeutics; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Fusion Pharmaceuticals Inc.; Debiopharm International SA; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts.

IMGN logo
IMGN
ImmunoGen, Inc.

Theresa G. Wingrove insider trading

ImmunoGen, Inc.

Dr. Theresa G. Wingrove has made 13 insider trades between 2014-2024, according to the Form 4 filled with the SEC. Most recently he sold 12,027 units of IMGN stock worth $352,391 on 5 Feb 2024.

The largest trade he's ever made was exercising 192,013 units of IMGN stock on 15 Sep 2023. As of 5 Feb 2024 he still owns at least 21,039 units of IMGN stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 12,027 $29.3 $352,391
Option
Stock Option (Right to Buy) 126,100 $5.25 $662,025
Option
Stock Option (right to buy) 2,667 $5.75 $15,335
Sale
Common Stock 187,667 $29.64 $5,562,450
Option
Common Stock 126,100 $5.25 $662,025
Option
Common Stock 2,667 $5.75 $15,335
Option
Stock Option (right to buy) 58,900 $4.83 $284,487
Option
Common Stock 58,900 $4.83 $284,487
Option
Common Stock 27,788 $4.55 $126,435
Option
Stock Option (right to buy) 27,788 $4.55 $126,435
Option
Stock Option (right to buy) 89,657 $5.32 $476,975
Option
Common Stock 89,657 $5.32 $476,975
Sale
Common Stock 117,445 $29.4 $3,452,883
Sale
Common Stock 164,424 $28.95 $4,760,075
Option
Common Stock 133,691 $10.65 $1,423,809
Option
Common Stock 30,733 $10.79 $331,609
Option
Stock Option (Right to Buy) 30,733 $10.79 $331,609
Option
Stock Option (Right to Buy) 133,691 $10.65 $1,423,809
Sale
Common Stock 6,792 $16.66 $113,155
Option
Stock Option (right to buy) 6,792 $10.65 $72,335
Option
Common Stock 6,792 $10.65 $72,335
Option
Stock Option (right to buy) 166,725 $4.55 $758,599
Sale
Common Stock 166,725 $15.85 $2,642,591
Option
Common Stock 166,725 $4.55 $758,599
Option
Stock Option (right to buy) 19,517 $10.65 $207,856
Option
Common Stock 19,517 $10.65 $207,856
Sale
Common Stock 19,517 $16.66 $325,153
Option
Stock Option (right to buy) 158,641 $4.55 $721,817
Option
Common Stock 158,641 $4.55 $721,817
Option
Stock Option (right to buy) 33,363 $4.55 $151,802
Sale
Common Stock 192,004 $14.4 $2,764,858
Option
Common Stock 33,363 $4.55 $151,802
Option
Common Stock 25,334 $2.68 $67,895
Option
Common Stock 50,000 $4.55 $227,500
Option
Common Stock 33,334 $3.05 $101,669
Option
Stock Option (right to buy) 25,334 $2.68 $67,895
Option
Stock Option (right to buy) 50,000 $4.55 $227,500
Sale
Common Stock 192,013 $15.44 $2,964,681
Option
Stock Option (right to buy) 33,334 $3.05 $101,669
Sale
Common Stock 16,147 $4.99 $80,574
Sale
Common Stock 11,032 $5.6 $61,779
Sale
Common Stock 11,379 $10.88 $123,804
Option
Common Stock 6,250 $9.85 $61,563
Option
Stock Option (right to buy) 6,250 $9.85 $61,563
Sale
Common Stock 6,250 $9.85 $61,563

ImmunoGen key executives

ImmunoGen, Inc. executives and other stock owners filed with the SEC: